Inflammatory Bowel Disease Center

Los Angeles, California 90048

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Severe Ulcerative Colitis

Studies at this site

• Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis — Completed
• Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease — Completed